en
svPress releases
Press release 2022-12-13
Xspray presents novel scientific data for XS004 in the Chronic Myeloid Leukemia (CML) session at the 2022 Meeting of the American Society of Hematology
Press release 2022-11-30
Xspray Pharma’s drug candidate XS004 granted orphan drug designation in the US for the treatment of acute lymphoblastic leukemia
Regulatory press release 2022-11-09
Interim Report Third Quarter 2022
Press release 2022-11-03
Xspray Announces 2 Poster Presentations for XS004 in Chronic Myeloid Leukemia (CML) at the American Society of Hematology (ASH) 2022 Annual Meeting
Regulatory press release 2022-10-31
Number of shares and votes in Xspray Pharma
-
Latest report
Interim Report Q3 2022 -
Subscribe
Get our latest press releases and reports
